The identification of mutations in the BRCA1 and BRCA2 genes, pivotal in HR repair of DSBs, was associated with a breast cancer risk as high as 70% and emphasized the importance of intact DDR in mitigating cancer risk (23, 24). This evidence concerns the gene BRCA2 and breast carcinoma.